SEC-sourced researchBeta
CDNA
CareDx, Inc.
Company comparison ↗
Data passport
- CIK
- 0001217234
- Exchange
- Nasdaq
- Business activity
- Services-Medical Laboratories · SIC 8071
- Financial inputs
- 6/6
- Filing date
- Nov 18, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 280,324,000.0000 | Feb 25, 2026 |
| December 2024 | 333,785,000.0000 | Feb 25, 2026 |
| December 2025 | 379,805,000.0000 | Feb 25, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 379,805,000.0000 | -21,354,000.0000 | 42,032,000.0000 | 413,228,000.0000 | 110,127,000.0000 | Feb 25, 2026 |
| December 2024 | 333,785,000.0000 | 52,549,000.0000 | 38,048,000.0000 | 491,050,000.0000 | 112,617,000.0000 | Feb 25, 2026 |
| December 2023 | 280,324,000.0000 | -190,284,000.0000 | -18,388,000.0000 | — | — | Feb 25, 2026 |
Explainable fundamental score
Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.
70/100
Profitability39
Growth64
Balance sheet73
Cash generation72
Data coverage100
Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $379.81M | Jan 1, 2025 – Dec 31, 2025 | Feb 25, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $333.79M | Jan 1, 2024 – Dec 31, 2024 | Feb 25, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$21.35M | Jan 1, 2025 – Dec 31, 2025 | Feb 25, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $42.03M | Jan 1, 2025 – Dec 31, 2025 | Feb 25, 2026 | 10-K |
| Total assetsAssets | $413.23M | Dec 31, 2025 | Feb 25, 2026 | 10-K |
| Total liabilitiesLiabilities | $110.13M | Dec 31, 2025 | Feb 25, 2026 | 10-K |
New filings
- 4CDNA · CareDx, Inc.Nov 18, 2026 · Other
- 144CDNA · CareDx, Inc.Nov 16, 2026 · Other
- 4CDNA · CareDx, Inc.Nov 16, 2026 · Other
- 4CDNA · CareDx, Inc.Nov 16, 2026 · Other
- 4CDNA · CareDx, Inc.Nov 12, 2026 · Other
- 144CDNA · CareDx, Inc.Nov 12, 2026 · Other
- 4CDNA · CareDx, Inc.Nov 12, 2026 · Other
- 144CDNA · CareDx, Inc.Nov 10, 2026 · Other
- SCHEDULE 13GCDNA · CareDx, Inc.Nov 10, 2026 · Other
- 4CDNA · CareDx, Inc.Nov 9, 2026 · Other
- 4CDNA · CareDx, Inc.Nov 9, 2026 · Other
- 144CDNA · CareDx, Inc.Nov 5, 2026 · Other
- 4CDNA · CareDx, Inc.Nov 4, 2026 · Other
- 4CDNA · CareDx, Inc.Nov 3, 2026 · Other
- 10-QCDNA · CareDx, Inc.Oct 29, 2026 · Periodic
- 8-KCDNA · CareDx, Inc.Oct 29, 2026 · Current event
- 4CDNA · CareDx, Inc.Oct 5, 2026 · Other
- 4CDNA · CareDx, Inc.Oct 5, 2026 · Other
- 4CDNA · CareDx, Inc.Oct 5, 2026 · Other
- 4CDNA · CareDx, Inc.Oct 5, 2026 · Other